Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule with the IUPAC name (1S,4S,5S)-1,4,5-trihydroxy-3-[3-(phenylthio)phenyl]cyclohex-2-ene-1-carboxylic acid. It has been cataloged as an experimental drug in DrugBank and is not currently approved for any therapeutic use. The molecule contains a cyclohexene core substituted with three hydroxyl groups and a carboxylic acid group; at the 3-position it carries a 3-(phenylthio)phenyl substituent. There is no published information on its mechanism of action or clinical indications. Its molecular formula is C19H18O5S and its average mass is approximately 358.41 g/mol[6][8]. No pharmacological class or biological target has been established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (1S,4S,5S)-1,4,5-trihydroxy-3-[3-(phenylthio)phenyl]cyclohex-2-ene-1-carboxylic acid.